Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jaymin B Morjaria, Rosalia Emma, Virginia Fuochi, Riccardo Polosa & Massimo Caruso. (2019) An evaluation of mepolizumab for the treatment of severe asthma. Expert Opinion on Biological Therapy 19:6, pages 491-500.
Read now
Read now
Garry M. Walsh. (2018) Recent developments in the use of biologics targeting IL-5, IL-4, or IL-13 in severe refractory asthma. Expert Review of Respiratory Medicine 12:11, pages 957-963.
Read now
Read now
Articles from other publishers (4)
Garry M. Walsh. 2023.
А. Г. Толкушин, М. Э. Холовня-Волосков & Н. Л. Погудина. (2021) Подготовка предложения о включении препарата в перечень ЖНВЛП. Критические пункты. Remedium:2, pages 91-99.
Crossref
Crossref
Joseena Iype & Michaela Fux. (2021) Basophils Orchestrating Eosinophils’ Chemotaxis and Function in Allergic Inflammation. Cells 10:4, pages 895.
Crossref
Crossref
Khodr Tello, Andreas Hoffmann, Björn Beutel, Timm Greulich, Claus Franz Vogelmeier, Manuel Jonas Richter, Stefan Kuhnert, Tobias Böselt, Peter Alter, Angelique Holland, Marco Idzko, Roland Buhl & Andreas Rembert Koczulla. (2019) Anti-interleukin-5 therapy (mepolizumab) in life-threatening asthma attack: A case-based discussion. Respiratory Medicine Case Reports 28, pages 100927.
Crossref
Crossref